H

Hospital Infanta Leonor | Internal Medicine Department

Research site
(Unclaimed)
Location
Avenida del Este 50, Madrid, Madrid, Spain
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 53
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

This study compares semaglutide, together with a lower dose of insulin glargine, to a higher dose of insulin glargine in participants with type 2 dia...

Enrolling
Obesity
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Insuline glargine U100 (reduced)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Enrolling
Attention Deficit Hyperactivity Disorder
Drug: Guanfacine hydrochloride (TAK-503)
Other: Placebo

The primary objective of this study is to evaluate if venetoclax when co administered with low-dose cytarabine (LDAC) improves overall survival (OS)...

Active, not recruiting
Acute Myeloid Leukemia (AML)
Drug: Placebo
Drug: Venetoclax
Status recently updated

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Begins enrollment this month
Enrolling
Atopic Dermatitis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

This is a multicenter, open label clinical trial evaluating the safety of the combination of belantamab mafodotin + the combination treatment VRd (bo...

Enrolling
Multiple Myeloma
Drug: Dexamethasone
Drug: Lenalidomide

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib (LOXO-30...

Enrolling
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

This is an open-label, multicenter study to evaluate the safety, tolerability, and efficacy of HMPL-523 in adult subjects with ITP.

Not yet enrolling
Blood Platelet Disorder
Thrombocytopenia
Drug: HMPL-523

Trial conditions

Multiple Myeloma (8 trials)
Plasma Cell Cancer (6 trials)
Atopic Dermatitis (5 trials)
Dermatitis (5 trials)
Infections (5 trials)
Communicable Diseases (4 trials)
Eczema (4 trials)
Leukemia (4 trials)
Psoriasis (4 trials)
COVID-19 (3 trials)

And 74 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems